Results for “research and development”
IBM Corporation
** International Business Machines Corporation (IBM) is a global technology and consulting powerhouse headquartered in Armonk, New York, renowned for its pioneering research, enterprise services, and a historic record of U.S. patent leadership. **CONTENT:** ## Overview International Business Machines Corporation, commonly known as **IBM**, stands as one of the world’s oldest and most diversified technology firms. With operations in more than **175 countries**, IBM delivers a portfolio that spans cloud computing, artificial intelligence (AI), quantum computing, cybersecurity, and enterprise‑level consulting. The company’s business model has evolved from hardware‑centric mainframes to a services‑driven, software‑heavy enterprise, positioning it as a critical infrastructure provider for governments, financial institutions, and Fortune‑500 corporations alike. IBM’s financial stature is reflected in its inclusion in the **Dow Jones Industrial Average** and its status as a publicly traded entity on the New York Stock Exchange (ticker: IBM). The firm’s commitment to innovation is anchored by the **largest industrial research organization** on the planet, operating 19 research labs across a dozen nations. From 1993 through 2021, IBM held the record for the most U.S. patents granted annually—a streak of 29 consecutive years that underscores its relentless focus on R&D. ## History/Background IBM traces its lineage to the **1911 merger** of four companies—Tabulating Machine Company, International Time Recording Company, the Computing Scale Company of America, and the Bundy Manufacturing Company—forming the **Computing‑Tabulating‑Recording Company (CTR)**. In 1924, under the visionary leadership of Thomas J. Watson Sr., CTR rebranded as **International Business Machines**, reflecting a broader ambition beyond mechanical tabulators. Key milestones include: - **1930s‑1940s:** Development of the **IBM 701** (the first commercial scientific computer) and the **IBM 1401**, cementing IBM’s dominance in early computing. - **1964:** Introduction of the **System/360**, a revolutionary family of compatible mainframes that standardized hardware and software across enterprises. - **1981:** Launch of the **IBM Personal Computer (PC)**, setting industry standards for hardware architecture and spawning the modern PC market. - **1990s:** Shift toward services under CEO Lou Gerstner, culminating in the acquisition of **PwC Consulting** (2002) and the formation of IBM Global Services. - **2011:** Unveiling of **Watson**, an AI platform that famously won *Jeopardy!* and later powered healthcare, finance, and customer‑service solutions. - **2020‑2024:** Aggressive push into hybrid cloud and quantum computing, highlighted by the acquisition of **Red Hat** (2019) and the launch of the **IBM Quantum System One**. ## Key Information - **Revenue (2023):** US $60.5 billion, with cloud and AI services accounting for over 30 % of total sales. - **Employees:** ≈ 280,000 worldwide, reflecting a mix of engineers, consultants, and research scientists. - **Patents:** More than 150,000 U.S. patents granted since 1993; a 2022 peak of 9,130 patents in a single year. - **Research Footprint:** 19 labs, including the iconic **Thomas J. Watson Research Center** in Yorktown Heights, NY, and international sites in Zurich, Tokyo, and Bangalore. - **Strategic Acquisitions:** Red Hat (2019, $34 billion), **Turbonomic** (2021), **Manta** (2022), and **Databand** (2023) to bolster hybrid‑cloud, AI‑ops, and data‑observability capabilities. - **Stock Symbol:** IBM (NYSE). - **Corporate Governance:** Board chaired by **Arvind Krishna**, who also serves as CEO, steering the company toward “**Intelligent Cloud and AI**” as its core growth engine. ## Significance IBM’s influence extends far beyond its balance sheet. Its **mainframe architecture** still underpins the transaction processing of banks, airlines, and governments, providing unmatched reliability and security. The company’s **research breakthroughs**—from the invention of the hard disk drive (1956) to the development of the relational database (1970s) and modern quantum processors—have reshaped entire technology ecosystems. IBM’s **patent dominance** illustrates a culture that prizes long‑term innovation over short‑term market hype, a rarity among today’s fast‑moving tech firms. The **Watson AI platform** pioneered the commercial use of natural‑language processing, influencing sectors from oncology (IBM Watson Health) to legal research (IBM Watson Legal). Meanwhile, IBM’s **hybrid‑cloud strategy**, anchored by Red Hat OpenShift, offers enterprises a seamless bridge between on‑premises data centers and public clouds—a critical capability as businesses navigate multi‑cloud environments. IBM’s legacy also includes a profound social impact: early adoption of **diversity initiatives**, the establishment of the **IBM Corporate Service Corps** (global pro‑bono consulting), and a commitment to **environmental sustainability**, targeting net‑zero greenhouse‑gas emissions by 2030. Collectively, these dimensions cement IBM as a catalyst for technological progress, corporate responsibility, and economic stability. **INFOBOX:** - Name: International Business Machines Corporation - Type: Multinational technology and consulting corporation - Date: Founded 1911 (as CTR), renamed IBM 1924 - Location: Armonk, New York, United States (global operations) - Known For: Pioneering computing hardware, AI (Watson), hybrid cloud, and record‑setting patent portfolio **TAGS:** IBM, technology, cloud computing, artificial intelligence, quantum computing, patents, research and development, corporate history
Economics & BusinessAbbVie Inc
AbbVie Inc. is a multinational American pharmaceutical company that has become one of the largest and most successful pharmaceutical companies in the world, known for its innovative treatments in various medical fields. ## Overview AbbVie Inc. is a pharmaceutical company that was spun off from **Abbott Laboratories** in 2013. The company's name was derived from the first two letters of its parent company, **A**bbott, and **V**ie, which is a reference to the Latin phrase "via," symbolizing the company's focus on finding new paths to healthcare. **AbbVie** is headquartered in **North Chicago, Illinois**, and has a diverse portfolio of pharmaceutical products that cater to various medical needs, including autoimmune diseases, oncology, and virology. **AbbVie** has evolved significantly since its inception, leveraging its research and development capabilities to create innovative treatments that have changed the lives of millions of people worldwide. The company has a strong presence in the global pharmaceutical market and has been recognized for its commitment to innovation, patient care, and sustainability. ## History/Background **AbbVie** was established in 2013 after **Abbott Laboratories** separated its research-based pharmaceutical business, which included its global portfolio of branded generic pharmaceuticals, biologics, and vaccines. The spin-off was motivated by the desire to create a more focused and agile company that could capitalize on growth opportunities in the pharmaceutical industry. **AbbVie** began trading on the **New York Stock Exchange** under the ticker symbol **ABBV**. The company's early years were marked by significant investments in research and development, as well as strategic acquisitions that expanded its pipeline of innovative treatments. **AbbVie** acquired **Phyton Biotech**, a biopharmaceutical company focused on developing innovative treatments for chronic diseases, in 2013. In 2014, the company acquired **Skyepharma**, a biopharmaceutical company with expertise in formulation development. ## Key Information **AbbVie** has a diverse portfolio of pharmaceutical products that cater to various medical needs. The company's flagship products include: - **Humira**, a biologic medication used to treat autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease. - **Imbruvica**, a medication used to treat various types of cancer, including mantle cell lymphoma and marginal zone lymphoma. - **Venclexta**, a medication used to treat various types of blood cancer, including acute myeloid leukemia and chronic lymphocytic leukemia. - **Skyla**, a medication used to prevent pregnancy in women. **AbbVie** has been recognized for its commitment to innovation, patient care, and sustainability. The company has been included in the **Dow Jones Sustainability Index**, which recognizes companies that have demonstrated strong sustainability performance. ## Significance **AbbVie** has become one of the largest and most successful pharmaceutical companies in the world, known for its innovative treatments in various medical fields. The company's commitment to innovation, patient care, and sustainability has made it a leader in the pharmaceutical industry. **AbbVie** continues to invest in research and development, with a focus on creating new treatments that address unmet medical needs. INFOBOX: - Name: AbbVie Inc. - Type: Pharmaceutical company - Date: 2013 (spun off from Abbott Laboratories) - Location: North Chicago, Illinois - Known For: Developing innovative treatments for autoimmune diseases, oncology, and virology TAGS: Pharmaceutical company, autoimmune diseases, oncology, virology, research and development, patient care, sustainability, innovation, Dow Jones Sustainability Index.
Economics & BusinessDow Inc.
**Dow Inc.** is a publicly traded American multinational chemical corporation that serves as the holding company for The Dow Chemical Company and its affiliated businesses.
Economics & BusinessSanofi
**Sanofi** **Sanofi** is a French multinational pharmaceutical and healthcare company headquartered in Paris, France, that develops and markets a wide range of pharmaceuticals, vaccines, and consumer
Economics & BusinessPfizer Inc
**Pfizer Inc** **Pfizer Inc** is a multinational pharmaceutical and biotechnology corporation headquartered in New York City, New York, United States, and is one of the oldest pharmaceutical companie
Economics & BusinessDell Technologies
**Dell Technologies** **Dell Technologies** is a multinational technology company that designs, manufactures, develops, and sells personal computers, servers, storage systems, and a wide range of oth
Economics & BusinessJohnson and Johnson
**Johnson & Johnson** **Johnson & Johnson** is a multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, United States. As one of